Pfizer Sees FY24 Adjusted Diluted EPS Guidance Range of $2.05-$2.25 Includes Expected Impact of Seagen Acquisition Versus Consensus Of $3.17
輝瑞預計,24財年調整後的攤薄後每股收益指導區間爲2.05美元至2.25美元,其中包括收購希根的預期影響與共識3.17美元的影響
Pfizer Sees FY24 Adjusted Diluted EPS Guidance Range of $2.05-$2.25 Includes Expected Impact of Seagen Acquisition Versus Consensus Of $3.17
輝瑞預計,24財年調整後的攤薄後每股收益指導區間爲2.05美元至2.25美元,其中包括收購希根的預期影響與共識3.17美元的影響
使用瀏覽器的分享功能,分享給你的好友吧